...
首页> 外文期刊>Journal of the Korean Physical Society >Dosimetric Comparisons of Intensity-Modulated Radiotherapy, Volumetric Modulated Arc Therapy, Tomotherapy, Stereotactic Radiosurgery, and Proton Therapy for Treatment of Patients with a Vestibular Schwannoma
【24h】

Dosimetric Comparisons of Intensity-Modulated Radiotherapy, Volumetric Modulated Arc Therapy, Tomotherapy, Stereotactic Radiosurgery, and Proton Therapy for Treatment of Patients with a Vestibular Schwannoma

机译:强度调制放疗,体积调制弧治疗,CooMotherapy,定向放射术和质子疗法的剂量测定比较治疗前庭施瓦南患者

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

This study compares the dosimetric characteristics of radiotherapy treatment methods for patients with a vestibular schwannoma. We generated and compared intensity-modulated radiotherapy (IMRT), volumetric modulated arc therapy (VMAT), tomotherapy (TOMO), and proton therapy (Proton) treatment plans among eight patients with a vestibular schwannoma who received stereotactic radiosurgery based on M3 (M3-SRS) treatment. The dose comparison of the planning target volume (PTV) was performed by calculating the homogeneity index (HI), conformity index (CI), coverage index (CVI), and equivalent uniform dose (EUD). A dose comparison for adjacent normal organs was performed by calculating the EUD and the normal tissue complication probability (NTCP). The PTV coverage showed excellent dose homogeneity and conformity on the target volume for M3-SRS treatment. The sparing of the organs at risk (OARs) was excellent in terms of dose delivery to most normal organs away from the target for Proton; however, the other modalities were also within the tolerance dose limit for the OARs. This study further confirmed the possibility of using radiotherapy, along with the use of other treatment methods, for patients with a vestibular schwannoma.
机译:该研究比较了前庭施瓦新瘤患者放射治疗方法的剂量测定特征。我们生成和比较强度调制的放疗(IMRT),体积调制弧治疗(VMAT),Tomotherapy(Tomo)和质子疗法(Proton)治疗计划,包括基于M3的前置施瓦科(M3- SRS)治疗。通过计算均匀性指数(HI),符合性指数(CI),覆盖率(CVI)和等同的均匀剂量(EUD)来进行计划靶体积(PTV)的剂量比较。通过计算EUD和正常组织并发症概率(NTCP)来进行相邻正常器官的剂量比较。 PTV覆盖率显示出优异的剂量均匀性和对目标体积的符合性,用于M3-SRS处理。在风险(OAR)的备用器官的备用在远离靶标的靶的剂量递送至多的常规器官方面非常出色;然而,其他方式也在桨的耐受剂量限制内。本研究进一步证实了使用放疗的可能性,以及使用其他治疗方法,用于前庭施瓦脉的患者。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号